Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02517671

Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
David Grant U.S. Air Force Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effects of 35 EECP sessions on cardiopulmonary training performance in healthy volunteers. Data from this study will be used to generate sample size and power calculations for feasibility of future EECP studies. The results of this study could provide evidence that can help active duty and Department of Defense beneficiaries optimize physical conditioning, endurance and overall health.

Detailed description

The purpose of this study is to assess the effects of 35 EECP sessions on cardiopulmonary training performance in healthy volunteers. Prior published and anecdotal evidence suggests that EECP should improve athletic performance. Data from this study will be used to generate sample size and power calculations for feasibility of future EECP studies. The results of this study could provide evidence that can help active duty and Department of Defense beneficiaries optimize physical conditioning, endurance and overall health. It could help active duty members maximize their physical training potential enabling them to better prepare for missions down range. Additionally, physiologic cardiopulmonary improvements may have the potential to decrease the conditioning time required for injured, post-operative and post-partum active duty members to return to duty.

Conditions

Interventions

TypeNameDescription
DEVICEEnhanced External Counterpulsation (EECP)EECP is a non-invasive therapy that has been approved by the United States Food and Drug Administration (FDA) for the management of refractory angina and heart failure. This study is using the device to potentially improve 1.5 mile run times and VO2max in healthy volunteers.

Timeline

Start date
2015-01-01
Primary completion
2017-10-07
Completion
2017-10-07
First posted
2015-08-07
Last updated
2018-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02517671. Inclusion in this directory is not an endorsement.